Targeting PDGFB reduced cancer cell growth and increased radiation sensitivity, suggesting the potential of PDGF-BB as a predictive marker for esophageal squamous cell carcinoma radiotherapy response. The gene discussed is PDGFB; the disease is esophageal squamous cell carcinoma.